Literature DB >> 3157574

Generation of T cell growth factor (TCGF)- dependent splenic lymphoid cell line with cell-mediated immunosuppressive reactivity against syngeneic murine tumor.

S Koyama, T Yoshioka, T Sakita, S Fujimoto.   

Abstract

Splenic T cells obtained from tumor-bearing mice could be cultured with T cell growth factor (TCGF) for over 12 months. The TCGF-dependent lymphoid cell line strongly inhibited cell-mediated anti-tumor immunity directed against syngeneic tumor. However, the suppression was non-specific for the given tumor. The cell line expanded with TCGF expressed a phenotypic characterization of T cells defined by monoclonal anti-Thy-1.2 antibody.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157574     DOI: 10.1016/0277-5379(85)90181-6

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  4 in total

1.  Randomized controlled study of postoperative adjuvant immunochemotherapy with Nocardia rubra cell wall skeleton (N-CWS) and Tegafur for gastric carcinoma.

Authors:  S Koyama; A Ozaki; Y Iwasaki; T Sakita; T Osuga; A Watanabe; M Suzuki; T Kawasaki; T Soma; T Tabuchi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma.

Authors:  T Ebihara; S Koyama; K Fukao; T Osuga
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Phenotypic analysis of nylon-wool-adherent suppressor cells that inhibit the effector process of tumour cell lysis by lymphokine-activated killer cells in patients with advanced gastric carcinoma.

Authors:  S Koyama; K Fukao
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Differential activation of lymphokine-activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T-cell growth factor in gastric cancer patients.

Authors:  S Koyama; T Ebihara; K Fukao; T Osuga
Journal:  Jpn J Cancer Res       Date:  1989-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.